Life Elevated: Examining Altitude-Related Effects on Mental illness

Tuesday, July 12, 2016
Life Elevated: Examining Altitude-Related Effects on Mental illness

Watch Video Recording:

Presented by 
Perry F. Renshaw, M.D., Ph.D.
Perry F. Renshaw, M.D., Ph.D.

Professor of Psychiatry

Medical Director, Rocky Mountain Network - Mental Illness Research, Education and Clinical Center (VISN 19 MIRECC)

University of Utah School of Medicine

Scientific Council Member (Joined 2007)

2001 Klerman Prize for Exceptional Clinical Research

2000 Independent Investigator Grant

1996, 1993 Young Investigator Grant

 

Dr. Renshaw's work is centered on the use of magnetic resonance spectroscopy (MRS) to identify changes in brain chemistry that are associated with mood and substance abuse disorders. These observations are used to identify novel therapies. His current clinical/MRS trials are focused on the use of citicoline as a treatment for methamphetamine dependence, creatine as a treatment for depression, and uridine as a treatment for bipolar disorder. In addition, the Renshaw laboratory is exploring the surprisingly strong association between suicide rates and altitude of residence. The underlying hypothesis is that brain metabolic changes associated with altitude increase the prevalence and severity of mood disorders.

Dr. Renshaw was Research Director and then Director of the McLean Hospital Brain Imaging Center and was on the faculty of Harvard Medical School prior to joining the University of Utah.

Moderated by
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation
 

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.